BGT vs TRU

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

36LOW

TRU

TRUSCREEN FPO NZX [TRU]

39LOW

Score Breakdown

BGT TRU
Technical
48
48
Catalyst
50
57
Sentiment
50
50
Fundamental
44
60
Momentum
52
60
Risk Gate
27
32

Key Metrics

BGT Metric TRU
$6.6MMarket Cap$13.1M
754KAvg Volume (20d)880K
N/AShort InterestN/A
$0.06152-Week High$0.025
$0.01652-Week Low$0.011
+0.0%Daily Change+0.0%
$0.017Reference Price$0.013
-202.2%ROE-125.4%
N/AProfit Margin-79.8%

Active Signals

BGT Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Trading below both moving averages — the trend is working against this one
●Lagging the Small Ords index — relative strength of 0.83, underperforming its peers
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.7 quarters)
●Strong revenue growth (+208%)

TRU Signals

●RSI drifting toward oversold territory — worth watching
●Lagging the Small Ords index — relative strength of 0.87, underperforming its peers
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (4.6x)
●Strong revenue growth (+120%)
●Near 52-week low (12% of range)

Ask Scout AI to compare BGT and TRU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BGT vs TTX →BIT vs BMT →BIT vs CYC →BIT vs EBR →BIT vs ECS →
BGT Full Analysis → TRU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).